Abstract
Transitional cell epithelium (urothelium) lines the urinary tract from the calyces of the kidney to the urethra, including the ducts of the prostate. Transitional cell cancer (TCC) accounts for 95% of all urothelial tumours. Almost all TCC originates in the bladder as ureteral and urethral cancers are relatively rare. Bladder cancer of this type will be the subject of this chapter.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Beahrs OH, Myers MH (1983) Manual for staging of cancer. American Joint Committee on Cancer. Lippincott, Philadelphia
Blandy JP, England HR, Evans SJW, Hope-Stone HF, Mair GMM, Mantell BS, Oliver RTD, Paris AMI, Risdon RA (1980) T3 bladder cancer - the case for salvage cystectomy. Br J Urol 52: 506–510
Bloom HGH, Hendry WF, Wallace DM, Skeet RG (1982) Treatment of T3 bladder cancer: controlled trial of preoperative radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol 54: 136–151
Bouffieux C, Denis L, Kurth KH, de Paine M, Sylvester R et le groupe genitourinaire de l’EORTC (1988) Quel chimiothera-pie intravesicale pour quelle tumeur de vessie. J Urol (Paris) (in print)
Carney M, le Due A (1979) L’enterocystoplastie apres cystecto-mie totale pour cancer de la vessie. Ann Urol (Paris) 2: 642–658
Corder MP, McFadden DB, Stump DC (1984) Chemotherapy of advanced transitional cell carcinoma of the bladder. In: Smith PH, Prout GR Jr (eds) Bladder cancer - urology I. Butterworths International Medical Reviews, London, pp 240–276
Crawford ED, Das S, Smith JA (1987) Preoperative radiation therapy in the treatment of bladder cancer. Urol Clin North Am 14: 781–787
Cutler SJ, Heney NM, Friedell GH (1982) Longitudinal study of patients with bladder cancer: factors associated with disease recurrence and progression. In: Bonney WW (ed) AUA monographs, vol 1: Bladder cancer. Williams and Wilkins, Baltimore, pp 35–46
Dalesio O, Schulman CC, Sylvester R, de Pauw M, Robinson M, Denis L, Smith P, Viggiano G, members of the EORTC Genito-Urinary Tract Cooperative Group (1983) Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer Genito-Urinary Tract Cooperative Group. J Urol 129: 730–733
Denis L (1987) Deeply invasive transitional cell carcinoma. In: Resnick MI, Kursh E (eds) Current therapy in genito-uri-nary surgery. Decker, Toronto, pp 63–69
Denis L, Smith P, Pavone-Macaluso M (1982) Clinical bladder cancer. Plenum, New York
Denis L, Braeckman J, Keuppens F (1984 a) Ultrasonography and computed tomography in the staging of bladder and prostate cancer. In: Kurth K, Debruyne F, Schroder F, Splinter T, Wagener T (eds) Progress and controversies in oncological urology. Liss, New York, pp 3–21
Denis L, Hendrickx G, Braeckman J, Debruyne R (1984 b) Interest of preoperative chemotherapy in the treatment of infiltrative bladder cancer. Acta Urol Belg 52: 579–582
Denis L, Murphy G, Prout G, Schroder F (1984 c) Controlled clinical trials in urologic oncology. Raven, New York
Denis L, Dalesio O, van Oosterom AT (1986 b) Bladder cancer. In: Slevin ML, Staquet MJ (eds) Randomized trials in cancer: a critical review by sites. Raven, New York, pp 645–660
Denis L, Niijima T, Prout GR, Schroder F. (eds) (1986 b) Developments in bladder cancer. Liss, New York
Denis L, Calais de Silva F, Hendrickx G (1988) Preoperative chemotherapy in T3 T4 NX M0 bladder cancer with cispla-tin and methotrexate. In: Smith PH, Pavone-Macaluso M (eds) Management of advanced cancer of the prostate and bladder. Liss, New York, pp 571–577
Fagg SL, Dawson-Edwards P, Hughes MA, Latief TN, Rolfe EB, Fielding JWL (1984) Cisplatinum (DDP) as initial treatment of invasive bladder cancer. Br J Urol 56: 296
Friedell GH (1976) Carcinoma, carcinoma in situ and “early lesions” of the uterine and the urinary bladder: introduction and definitions. Cancer Res 36: 2482–2484
Hall RR, Heath AB (1981) Radiotherapy and cystectomy for T3 bladder cancer. Br J Urol 53: 598–601
Hall RR, Newling DWW, Ramsden PD, Richards B, Robinson MRG, Smith PH (1984) Treatment of invasive bladder cancer by local resection and high dose methotrexate. Br J Urol 56: 668–672
Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Haferman MD, Hawkings IR (1983) Superficial bladder cancer: progression and recurrence. J Urol 130:1083–1086
Hermanek P, Sobin LH (1987) TNM classification of malignant tumours. Springer, Berlin Heidelberg New York
Herr H, Landone VP, Whitmore FW Jr (1987) An overview of intravesical chemotherapy for superficial bladder tumours. J Urol 138: 1363–1368
Hohenfellner RH, Jacobi GH (1984) Radical cystectomy without preoperative radiotherapy for invasive bladder carcinoma: a justified approach? In: Kurth KH, Debruyne FMJ, Schroder FH, Splinter TAW, Wagener TDJ (eds) Progress and controversies in oncological urology. Liss, New York, pp 313–342
Jakse G, Frommhold H (1984) Combined radiation and chemotherapy for locally advanced bladder cancer. In: Kurth KH, Debruyne F, Schroder F, Splinter T, Wagener T (eds) Progress and controversies in oncological urology. Liss, New York, pp 365–372
Jakse G, Marberger H (1985) Culp D, Loening S. (eds) Tumours of the ureter in genito-urinary oncology. Lea and Fehger, Philadelphia, p 277
Jakse G, Hofstadter F, Leitner G (1980) Carcinoma in situ der Harnblase. Urologe [A] 19: 93–99
Kock NG (1971) Ileostomy without external appliances. Ann Surg 173: 545–566
Koss LG, Deitch D, Ramanathan R, Sherman A (1985) Diagnostic value of cytology of voided urine. Acta Cytol (Baltimore) 29: 810–816
Kurth KH (1984) Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival. In: Küss R, Khoury S, Denis L, Murphy GP, Karr JP (eds) Bladder cancer. A. Pathology, diagnosis and surgery. Liss, New York, pp 307–318
Medical Research Council Working Party on Urological Cancer (1985) The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer: an MRC study. Br J Urol 57: 680–685
Miyakawa M, Raghavan D, Riedl H, Robinson MRG, Worden JN (1986) Quality of life assessment in bladder cancer clinical trials: conceptual, methodological and practical issues. In: Denis L, Niijima T, Prout GR, Schroder F (eds) Consensus in bladder cancer. Liss, New York, pp 149–170
Morales A (1984) Long term results and complications of intracavitary bacillus Calmette-Guerin therapy for bladder cancer. J Urol 132: 452–457
Neal DE (1985) Complications of ileal conduit diversion in adults with cancer followed up for at least five years. Br Med J [Clin Res] 290: 1695–1697
Niijima T, Nakamura S (1982) Transurethral ultrasonography: bladder cancer staging and other clinical application. In: Denis L, Smith PH, Pavone-Macaluso M (eds) Clinical bladder cancer. Plenum, New York, pp 47–54
Powell PH, Manohar V, Ramsden PD, Hall RR (1984) A flexible cystoscope. Br J Urol 56: 622–624
Prout GR Jr, Kopp J (1984) Evaluation and management of patients with primary bladder carcinoma protocols of the NBCP Collaborative Group A. In: Denis L, Murphy G, Prout G, Schroder F (eds) Controlled clinical trials. Raven, New York, pp 221–240
Prout GR Jr, Griffin PP, Shipley WU (1979) Bladder carcinoma as a systemic disease. Cancer 43: 2532–2539
Prout GR Jr, Koontz WW Jr, Coombs LJ, Hawkings IR, Friedell GH for the National Bladder Collaborative Group A (1983) Long term fate of 90 patients with superficial bladder cancer randomly assigned to receive or not receive thiotepa. J Urol 130: 677–680
Raghavan D, Pearson B, Duval P, Rogers J, Meagher M, Wines R, Mameghan H, Boulas J, Green D (1985) Initial intravenous cisplatinum therapy: improved management for invasive high risk bladder cancer? J Urol 133: 399–402
Richards B, Schroder F (1983) Superficial bladder tumours. Liss, New York
Richards B, Bastable JR, Freedman L, Glashan RW, Harris G, Newling W, Robinson MR, Smith PH (1983) Adjuvant chemotherapy with doxorubicin (adriamycin) and 5-fluoro-uracil in T3 NX M0 bladder cancer treated with ratiother-apy. Br J Urol 55: 386–391
Richards B, Aso Y, Bollack C, Fossa S, Koontz W, Matsuda M, Matsumoto K, Prout G, van der Werf-Messing B, Wolf H (1986) Prognostic factors in infiltrating bladder cancer. In: Denis L, Niijima T, Prout GR, Schroder F (eds) Developments in bladder cancer. Liss, New York, pp 271–286
Shipley WV, Rose MA (1984) Bladder cancer. The selection of patients for full-dose irradiation. Cancer 55: 2278–2284
Shipley WV, Prout GR Jr, Einstein AB (1987) Treatment of invasive bladder cancer by cisplatin and irradiation in patients unsuited for surgery. JAMA 258: 931–937
Skinner DG (1982) Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 128: 34–36
Skinner D, Lieskorsky G, Boyd SD (1987) Continuing experience with the continent ileal reservoir (Kock pouch) as an alternative to cutaneous urinary diversion: an update after 250 cases. J Urol 137: 1140–1145
Slack NH, Prout GR (1980) The heterogeneity of invasive bladder carcinoma and different responses to treatment. J Urol 123: 644–652
Slack NH, Bross IDJ, Prout GR Jr (1977) Five year follow-up results of a collaborative study of therapies for carcinoma of the bladder. J Surg Oncol 9: 393–405
Socquet Y (1981) Combined surgery and adjuvant chemotherapy with high dose methotrexate and folinic acid rescue (HDMTX-CF) for infiltrating tumours of the bladder. Br J Urol 53: 439–443
Soloway M, Kurth KH, Herr H, Huland H, Denis L, Suzuki K, Blandy J, Hisazumi H, Koontz W, Tsugawa R (1986) Surgical techniques in the management of patients with superficial bladder cancer. In: Denis L, Niijima T, Prout GR, Schroder F. (eds) Developments in bladder cancer. Liss, New York, pp 123–132
Sonoda T, Debruyne FMJ, Prout GR Jr, Matsuda M, Blandy JP, Hohenfellner R, Keuppens F, Matsumoto K, Ogata J, Whitmore WF Jr (1986) Surgical techniques in invasive bladder cancer. In: Denis L, Niijima T, Prout GR, Schroder F (eds) Developments in bladder cancer. Liss, New York, pp 138–148
Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Sogoni PC, Morse MJ, Fair WR, Whitmore WF, Vaughan ED, Bander N, Weiselberg LR, Geller N, Hollander PS (1988) M-VAC for advanced transitional cell carcinoma of urothe-lium. J Urol 139: 461–469
Stoter G (1985) Chemotherapy for metastatic bladder carcinoma. World J Urol 3: 110–114
Stoter G, Child JA, Fossa SD, Boven E, Denis L, Splinter WG, van Oosterom AT, de Pauw M, Sylvester R for the EORTC Genito-Urinary Group (1987) Combination chemotherapy with cisplatin (CDDP) and methotrexate (MIX) in advanced transitional cell cancer of the bladder. J Urol 137: 663–667
Sylvester R (1985) The analysis of results in prophylactic superficial bladder cancer. In: Schroder FH, Richards B (eds) Superficial bladder tumours. Liss, New York, pp 3–11
Sylvester TAW, ten Kate FJW, Schroder FH, Denis L, Newling D, Jones WG, Jacquimin D, Becker-Kruger CGG, Sloter G, de Voegt HJ, de Paine M (1988) Neo-adjuvant chemotherapy in T3–4 NO-X MO transitional cell carcinoma of the bladder. In: Khoury S, Murphy G, Chatelain C, Dews L (eds) Therapeutic progress in urological cancers. Liss, New York (in print)
van der Werf-Messing B (1983) Radiation therapy of carcinoma of the urinary bladder in clinical bladder cancer. In: Denis L, Murphy G, Prout G, Schroder F (eds) Controlled clinical trials in urologic oncology. Raven, New York, pp 83–89
Van der Werf-Messing B, Menon RS, Hopp WC (1984) Interstitial radiotherapy of carcinoma of the bladder at the Rotterdam Radiotherapy Institute (RRTI). In: Küss R, Khoury S, Denis L, Murphy G, Karr JP (eds) Bladder cancer. Liss, New York, pp 71–85
Whitmore WF, Batata MA, Ghoneim MA, Grabstald H, Unal A (1977) Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. J Urol 118: 184–187
Wolf H, Olsen PR, Hojgaard K (1985) Urothelial dysplasia concomitant with bladder tumours as a determinant factor for future new occurrences in patients treated with full course radiotherapy. Lancet I: 1005
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Denis, L., Hall, R., Jakse, G. (1989). Cancers of the Urinary Bladder, Ureters and Urethra. In: Veronesi, U., Arnesjø, B., Burn, I., Denis, L., Mazzeo, F. (eds) Surgical Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72646-0_59
Download citation
DOI: https://doi.org/10.1007/978-3-642-72646-0_59
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72648-4
Online ISBN: 978-3-642-72646-0
eBook Packages: Springer Book Archive